Ana Fortuna

Scopus Author ID Ciência ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Venues

The Analyst

Antibiotics (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Pharmaceutics

Faculty of Pharmacy of the University of Coimbra

Faculty of Pharmacy University of Coimbra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Faculty of Pharmacy of the University of Coimbra

Portugal

Professor

Education History

Faculty of Pharmacy University of Coimbra - Oct 04 2011

Portugal

PHD :: Laboratory of Pharmacology

Publications

Maria Graça Campos, Maria China, Mariana Cláudio, Miguel Capinha, Rita Torres, Simão Oliveira, Ana Fortuna
Drug-Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Andreia Carona, Joana Bicker, Carla Fonseca, Maria da Graça Campos, Amílcar Falcão, Ana Fortuna
Development and validation of an HPLC-DAD method for the quantification of cannabigerol, cannabidiol, cannabinol and cannabichromene in human plasma and mouse matrices. The Analyst 149 (14) (2024)
Andreia Carona, Joana Bicker, Carla Fonseca, Maria da Graça Campos, Amílcar Falcão, Ana Fortuna
Development and validation of an HPLC-DAD method for the quantification of cannabigerol, cannabidiol, cannabinol and cannabichromene in human plasma and mouse matrices. The Analyst 149 (14) (2024)
Andreia Carona, Joana Bicker, Carla Fonseca, Maria da Graça Campos, Amílcar Falcão, Ana Fortuna
Development and validation of an HPLC-DAD method for the quantification of cannabigerol, cannabidiol, cannabinol and cannabichromene in human plasma and mouse matrices. The Analyst (2024)
Maria Graça Campos, Maria China, Mariana Cláudio, Miguel Capinha, Rita Torres, Simão Oliveira, Ana Fortuna
Drug-Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Maria Aquino, Maria Tinoco, Joana Bicker, Amílcar Falcão, Marília Rocha, Ana Fortuna
Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Maria Aquino, Maria Tinoco, Joana Bicker, Amílcar Falcão, Marília Rocha, Ana Fortuna
Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Rui Silva, Helena Colom, Joana Bicker, Anabela Almeida, Ana Silva, Francisco Sales, Isabel Santana, Amílcar Falcão, Ana Fortuna
Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy. Pharmaceutics 15 (6) (2023)
Rui Silva, Helena Colom, Joana Bicker, Anabela Almeida, Ana Silva, Francisco Sales, Isabel Santana, Amílcar Falcão, Ana Fortuna
Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy. Pharmaceutics 15 (6) (2023)
Jordi Olloquequi, Miren Etchetto, Amanda Cano, Ana Fortuna, Joana Bicker, Elena Sánchez-Lopez, Cristian Paz, Jesús Ureña, Ester Verdaguer, Carme Auladell, Antonio Camins Espuny
Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment. International journal of molecular sciences 24 (18) (2023)
Joana Gonçalves, Gilberto Alves, Andreia Carona, Joana Bicker, Carla Vitorino, Amílcar Falcão, Ana Fortuna
Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration. Pharmaceutical research 37 (4) (2020)
Joana Bicker, Gilberto Alves, Amílcar Falcão, Ana Fortuna
Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics. British journal of pharmacology 177 (10) (2020)
Joana Santos, Natália António, Marília Rocha, Ana Fortuna
Impact of direct oral anticoagulant off-label doses on clinical outcomes of atrial fibrillation patients: A systematic review. British journal of clinical pharmacology 86 (3) (2020)
Paulo Magalhães, Gilberto Alves, Ana Fortuna, Adrián Llerena, Amílcar Falcão
Real-world clinical characterization of subjects with depression treated with antidepressant drugs focused on (non-)genetic factors, pharmacokinetics, and clinical outcomes: GnG-PK/PD-AD study. Experimental and clinical psychopharmacology 28 (2) (2019)
Ana Cláudia Paiva Santos, Francisco J Veiga, Joana A D Sequeira, Ana Fortuna, Amílcar Falcão, Irina Pereira, Pravin Pattekari, Carlos Fontes Ribeiro, António José Ribeiro
First-time oral administration of resveratrol-loaded layer-by-layer nanoparticles to rats - a pharmacokinetics study. The Analyst 144 (6) (2019)

Ana Fortuna.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ana Fortuna